Association of intratumoral pharmacokinetics of fluorouracil with clinical response
- 14 May 1994
- journal article
- Published by Elsevier in The Lancet
- Vol. 343 (8907) , 1184-1187
- https://doi.org/10.1016/s0140-6736(94)92399-x
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- The non-invasive monitoring of low dose, infusional 5-fluorouracil and its modulation by interferon-α using in vivo 19F magnetic resonance spectroscopy in patients with colorectal cancer: A pilot studyAnnals of Oncology, 1993
- A mathematical model of the kinetics of 5-fluorouracil and its metabolites in cancer patientsCancer Chemotherapy and Pharmacology, 1991
- Tumor trapping of 5-fluorouracil: in vivo 19F NMR spectroscopic pharmacokinetics in tumor-bearing humans and rabbits.Proceedings of the National Academy of Sciences, 1990
- Prediction of 5-fluorouracil cytotoxicity towards the Walker carcinosarcoma using peak integrals of fluoronucleotides measured by MRS in vivoBritish Journal of Cancer, 1989
- Fluorine-19 NMR spectroscopic studies of the metabolism of 5-fluorouracil in the liver of patients undergoing chemotherapyMagnetic Resonance Imaging, 1987
- Facilitated transport of uracil and 5‐fluorouracil, and permeation of orotic acid into cultured mammalian cellsJournal of Cellular Physiology, 1980